Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anny Shai

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Research|June 10, 2010
E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in miceAnny Shai, Henry C Pitot, Paul F Lambert
Cancer Research|April 17, 2008
p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancersAnny Shai, Henry C Pitot, Paul F Lambert
Cancer Research|February 20, 2007
The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activitiesAnny Shai, Tiffany Brake, Chamorro Somoza, et al.
Cancer Research|May 24, 2015
TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung TumorigenesisAnny Shai, David Dankort, Joseph Juan, et al.
Cancer Research|March 25, 2010
A role for HPV16 E5 in cervical carcinogenesisJohn P Maufort, Anny Shai, Henry C Pitot, et al.
Cancer Research|December 3, 2008
Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancerSang-Hyuk Chung, Kerri Wiedmeyer, Anny Shai, et al.
Virology|November 7, 2008
Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosisIngeborg Zehbe, Christina Richard, Correne A DeCarlo, et al.
Genes & Development|September 18, 2009
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPeter Olson, Jun Lu, Hao Zhang, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2025
3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastomaViva Voong, Sol Beccari, Elaheh Hashemi, et al.
Neuro-Oncology|December 23, 2023
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expressionChristina L Appin, Chibo Hong, Abigail K Suwala, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Research|June 10, 2010
E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in miceAnny Shai, Henry C Pitot, Paul F Lambert
Cancer Research|April 17, 2008
p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancersAnny Shai, Henry C Pitot, Paul F Lambert
Cancer Research|February 20, 2007
The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activitiesAnny Shai, Tiffany Brake, Chamorro Somoza, et al.
Cancer Research|May 24, 2015
TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung TumorigenesisAnny Shai, David Dankort, Joseph Juan, et al.
Cancer Research|March 25, 2010
A role for HPV16 E5 in cervical carcinogenesisJohn P Maufort, Anny Shai, Henry C Pitot, et al.
Cancer Research|December 3, 2008
Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancerSang-Hyuk Chung, Kerri Wiedmeyer, Anny Shai, et al.
Virology|November 7, 2008
Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosisIngeborg Zehbe, Christina Richard, Correne A DeCarlo, et al.
Genes & Development|September 18, 2009
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPeter Olson, Jun Lu, Hao Zhang, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2025
3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastomaViva Voong, Sol Beccari, Elaheh Hashemi, et al.
Neuro-Oncology|December 23, 2023
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expressionChristina L Appin, Chibo Hong, Abigail K Suwala, et al.
Pageof 3